drugset / Trial / NCT05095519
Hepatocellular Carcinoma Imaging Using PSMA PET/CT
NaSingle-groupOpen-labelDiagnostic
Summary
The purpose of the research is to evaluate the use of a PSMA PET/CT (Prostate Specific Membrane Antigen Positron Emission Tomography/Computerized Tomography) scan in the diagnosis of HCC (hepatocellular carcinoma) and comparing it to standard scanning techniques with CT (Computed Tomography) or MRI (Magnetic Resonance Imaging).
Timeline
- Start
- 2021-09-08
- Primary completion
- 2026-03-08
- Completion
- 2026-09-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | 18F-DCFPyL | Diagnostic / imaging agent | 3.5 mbq/kg | Intravenous |